IDSA Home

What's New

AABB and IDSA Release Considerations for Clinicians on Emergency Use of COVID-19 Convalescent Plasma

AABB and the Infectious Diseases Society of America issued today a resource document outlining considerations for clinicians on the use of COVID-19 convalescent plasma under the Emergency Use Authorization granted by the Food and Drug Administration.

Pfizer-BioNTech COVID-19 Vaccine

On December 11, 2020, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine to prevent COVID-19 disease. The vaccine, Pfizer-BioNTech’s BNT162b2, is authorized for use in individuals 16 years of age and older. Read more on the COVID-19 Real Time Learning Network, brought to you by CDC & IDSA.

Response from IDSA President Barbara Alexander MD, MSH, FIDSA to FDA EUA of Pfizer-BioNTech COVID-19 Vaccine: FDA Authorization Is First of Critical Steps Ahead

“The first Emergency Use Authorization of a vaccine against the novel coronavirus in the United States offers a promising opportunity to reverse the trajectory of the COVID-19 pandemic." Read Full Statement

Representatives Introduce PASTEUR Act to Build, Protect Antibiotic Access

Congressional Rep. Mike Doyle (D-PA) and Rep. Drew Ferguson (R-GA) today introduced The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act

IDSA Submits Comments on NIH COVID-19 Research Plan

In a Dec. 7 letter to National Institutes of Health Director Francis Collins, MD, PhD, on the agency’s Strategic Plan for COVID-19 Research, IDSA President Barbara Alexander, MD, MHS, FIDSA, calls for cross-cutting strategies

IDSA and HIVMA Applaud Selection of Dr. Rochelle Walensky to Lead CDC

The Infectious Diseases Society of America and its HIV Medicine Association welcome President-elect Biden’s selection of Dr. Rochelle Walensky to lead the U.S. Centers for Disease Control and Prevention.

IDWeek 2020

Dr. Fauci Kicks Off IDWeek2020’s “Chasing the Sun” Event

Anthony Fauci, M.D., FIDSA, director of the National Institute of Allergy and Infectious Diseases, kicked off this year’s premier virtual infectious diseases conference with an overview of the public health and scientific challenges of COVID-19 in the United States. Login to this year’s program now.

The Voice of Truth About the Pandemic: Thank You Dr. Fauci

Renowned leaders, policy makers and medical experts offer their thanks to NIAID Director Anthony Fauci, M.D., FIDSA, as he kicks off IDWeek 2020 and the global Chasing the Sun event.